| Product Code: ETC7657038 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Next Generation Cancer Diagnostics Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 Israel Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 Israel Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Israel Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.8 Israel Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 Israel Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Technological advancements in cancer diagnostics |
4.2.3 Rising demand for personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for new diagnostic technologies |
4.3.2 High costs associated with next generation cancer diagnostics |
5 Israel Next Generation Cancer Diagnostics Market Trends |
6 Israel Next Generation Cancer Diagnostics Market, By Types |
6.1 Israel Next Generation Cancer Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F |
6.1.4 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F |
6.1.5 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F |
6.1.6 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F |
6.1.7 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F |
6.2 Israel Next Generation Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F |
6.2.3 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F |
6.2.4 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F |
6.2.5 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F |
6.2.6 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F |
6.3 Israel Next Generation Cancer Diagnostics Market, By Cancer |
6.3.1 Overview and Analysis |
6.3.2 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.4 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.3.6 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Next Generation Cancer Diagnostics Market, By Function |
6.4.1 Overview and Analysis |
6.4.2 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F |
6.4.3 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.4.4 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F |
6.4.5 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F |
6.4.6 Israel Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F |
7 Israel Next Generation Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Israel Next Generation Cancer Diagnostics Market Export to Major Countries |
7.2 Israel Next Generation Cancer Diagnostics Market Imports from Major Countries |
8 Israel Next Generation Cancer Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of next generation cancer diagnostic technologies in Israel |
8.2 Number of research and development collaborations in the field of cancer diagnostics |
8.3 Rate of investment in Israeli companies developing next generation cancer diagnostic solutions |
9 Israel Next Generation Cancer Diagnostics Market - Opportunity Assessment |
9.1 Israel Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Israel Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
9.4 Israel Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
10 Israel Next Generation Cancer Diagnostics Market - Competitive Landscape |
10.1 Israel Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Israel Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here